XML 62 R41.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Compensation Level 3 (Tables)
12 Months Ended
Dec. 31, 2020
Share-based Payment Arrangement, Noncash Expense [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] The fair values of our stock options are calculated using the following weighted average assumptions, based on the methods described above:
Years Ended December 31,
Assumptions202020192018
Dividend yield1.7%1.7%1.8%
Expected volatility18.0%19.8%18.5%
Risk-free interest rate1.4%2.5%2.4%
Expected holding period (years)3.74.04.0
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
The following table summarizes certain information with respect to stock option and restricted share compensation included in our Consolidated Statement of Operations:
Years Ended December 31,
 202020192018
 (In thousands)
Total pretax employee share-based compensation expense included in net income$14,103 $15,029 $15,626 
Income tax benefit related to share-based compensation included in net income$3,417 $3,842 $3,998 
Share-based Payment Arrangement, Option, Activity [Table Text Block]
The following table sets forth stock option activity for the year ended December 31, 2020 (shares reported in whole numbers):
OptionsWeighted-Average
Exercise Price
Outstanding at December 31, 20197,309,446 $27.53 
Granted963,940 $50.82 
Exercised(1,361,321)$19.59 
Outstanding at December 31, 20206,912,065 $32.34 
Exercisable at December 31, 20205,101,243 $27.46 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]
Set forth below is certain information related to stock options outstanding and exercisable at December 31, 2020 (shares reported in whole numbers):
 Options OutstandingOptions Exercisable
Range of Exercise PriceNumber
Outstanding at
December 31, 2020
Weighted-Average Remaining Contractual Life
(in years)
Weighted-
Average Exercise Price
Number
Exercisable at
December 31, 2020
Weighted-
Average Exercise Price
$15.00 — 25.002,581,498 2.4$21.70 2,581,498 $21.70 
$25.01 — 35.001,419,762 4.1$29.25 1,419,762 $29.25 
$35.01 — 45.001,946,865 5.5$39.54 1,099,983 $38.68 
$45.01 — 55.00963,940 7.1$50.82 — $— 
$0.00 — 55.00
6,912,065 4.3$32.34 5,101,243 $27.46 
Other Information Pertaining to Stock Option Activity [Table Text Block]
Other information pertaining to stock options was as follows (in thousands, except weighted-average grant date fair value):
Years Ended December 31,
202020192018
Weighted average grant-date fair value of stock options granted$6.44 $6.86 $5.52 
Total fair value of stock options vested$5,535 $7,250 $6,857 
Total intrinsic value of stock options exercised$41,995 $65,023 $48,643 
Cash received from the exercise of stock options
$26,671 $40,922 $24,517 
Recognized compensation expense
$5,668 $6,314 $6,648 
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
Restricted share award activity was as follows (share awards reported in whole numbers):
Restricted
Share Awards
Weighted-Average
Grant-Date
Fair Value
Nonvested restricted share awards at December 31, 2019288,065 $38.09 
Granted113,872 $50.82 
Vested(158,408)$35.82 
Nonvested restricted share awards at December 31, 2020243,529 $45.52 
Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Restricted
Share Units
Weighted-Average
Grant-Date
Fair Value
Nonvested restricted share units at December 31, 2019151,452 $36.79 
Granted67,151 $48.89 
Vested(78,453)$34.69 
Forfeited and other(4,842)$41.70 
Nonvested restricted share units at December 31, 2020135,308 $43.83